Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02928172 · ClinicalTrials.gov registry record · NA
Comparison of Two Electroencephalograms (EEG) Monitors in Patients Undergoing General Anesthesia
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02928172 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 60 participants.
The verdict
NCT02928172, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Hypothesis: There is a statistically measurable correlation between qNOX and rough clinical signs of insufficient anti-nociception such as movements during Laryngeal Mask Airway (LMA) insertion, skin Incision, LMA removal. It will reduce the problem of anticipating the nociception in patients undergoing general anesthesia. Objectives: 1. to compare two indexes of hypnosis, the qCON (Quantium Medical, Spain) with the Bispectral index (BIS™) (Covidien, Boulder CO. USA), in patients undergoing surgery under sedation and general anesthesia. 2. to assess the qNOX index of pain/nociception (Quantium Medical, Barcelona, Spain) and the qCON index of hypnosis. 3. to assess qNOX reliability as a specific indicator of response to nociceptive stimulation.
Interventions
- DEVICE qCON-qNOX
- DEVICE BIS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2023-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02928172
The ClinicalTrials.gov registry entry for NCT02928172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which qCON-qNOX is the first listed.
NCT02928172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02928172 about?
NCT02928172 is a clinical study titled "Comparison of Two Electroencephalograms (EEG) Monitors in Patients Undergoing General Anesthesia". Hypothesis: There is a statistically measurable correlation between qNOX and rough clinical signs of insufficient anti-nociception such as movements during Laryngeal Mask Airway (LMA) insertion, skin Incision, LMA removal. It will reduce the problem of anticipating the nociception in patients under...
What is the current status of trial NCT02928172?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-01-02. Estimated completion is 2023-02-20.
What interventions are being tested in trial NCT02928172?
The interventions under investigation include: qCON-qNOX (DEVICE), BIS (DEVICE).
Who is sponsoring clinical trial NCT02928172?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.